MEASUREMENT METHODS - ANNOTATIONS
The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml ).
Term: ex vivo microscopy
Accession: MMO:0000109
browse the term
Definition: Examination or observation of material performed outside the living body using a microscope, an instrument used to obtain an enlarged image of small objects and reveal details of structure not otherwise distinguishable.
Q
Colcr2
Colorectal carcinoma resistance QTL 2
IDA
RGD
PMID:17510081
RGD:1625309
NCBI chr15:2,266,368...22,711,984
Q
Colcr5
Colorectal carcinoma resistance QTL 5
IDA
RGD
PMID:17510081
RGD:1625309
NCBI chr 6:122,549,046...137,801,795
Q
Colcr8
Colorectal carcinoma resistance QTL 8
IDA
RGD
PMID:17510081
RGD:1625309
NCBI chr18:22,066,242...52,293,055
Q
Colcr9
Colorectal carcinoma resistance QTL 9
IDA
RGD
PMID:17510081
RGD:1625309
NCBI chr20:1,530,655...46,530,655
Q
Eae2
Experimental allergic encephalomyelitis QTL 2
IDA
RGD
PMID:9973459
RGD:69694
NCBI chr 4:21,333,343...39,505,420
Q
Eae3
Experimental allergic encephalomyelitis QTL 3
IDA
RGD
PMID:9973459
RGD:69694
NCBI chr10:26,521,957...61,345,413
Q
Eau1
Experimental allergic uveoretinitis QTL 1
IDA
RGD
PMID:10323205
RGD:61073
NCBI chr 4:70,362,013...132,642,728
Q
Eau2
Experimental allergic uveoretinitis QTL 2
IDA
RGD
PMID:10323205
RGD:61073
NCBI chr12:8,525,423...28,064,601
Q
Eau3
Experimental allergic uveoretinitis QTL 3
IDA
RGD
PMID:10323205
RGD:61073
NCBI chr10:34,490,559...45,579,777
Q
Eau4
Experimental allergic uveoretinitis QTL 4
IDA
RGD
PMID:18453595
RGD:2296064
NCBI chr 3:137,398,739...169,034,231
Q
Eau5
Experimental allergic uveoretinitis QTL 5
IDA
RGD
PMID:18453595
RGD:2296064
NCBI chr 2:202,446,871...237,938,339
Q
Eau6
Experimental allergic uveoretinitis QTL 6
IDA
RGD
PMID:18453595
RGD:2296064
NCBI chr 7:84,257,275...129,257,275
Q
Eau7
Experimental allergic uveoretinitis QTL 7
IDA
RGD
PMID:18453595
RGD:2296064
NCBI chr10:27,957,626...34,490,668
Q
Eau8
Experimental allergic uveoretinitis QTL 8
IDA
RGD
PMID:18453595
RGD:2296064
NCBI chr19:17,154,433...57,337,602
Q
Eau9
Experimental allergic uveoretinitis QTL 9
IDA
RGD
PMID:18453595
RGD:2296064
NCBI chr10:65,927,233...82,565,079
Q
Edcs1
Endometrial carcinoma susceptibility QTL1
IDA
RGD
PMID:11745480
RGD:1599856
NCBI chr11:18,976,208...24,697,116
Q
Edcs2
Endometrial carcinoma susceptibility QTL2
IDA
RGD
PMID:11745480
RGD:1599856
NCBI chr12:6,833,190...17,870,186
Q
Edcs3
Endometrial carcinoma susceptibility QTL3
IDA
RGD
PMID:11745480
RGD:1599856
NCBI chr20:1...25,159,026
Q
Edcs4
Endometrial carcinoma susceptibility QTL 4
IDA
RGD
PMID:11745480
RGD:1599856
NCBI chr 1:206,081,677...251,081,677
Q
Edcs5
Endometrial carcinoma susceptibility QTL 5
IDA
RGD
PMID:11745480
RGD:1599856
NCBI chr17:57,246,723...70,852,846
Q
Gdil1
Gastrointestinal dilation QTL 1
IDA
RGD
PMID:21915282
RGD:6480217
NCBI chr 2:56,660,879...74,786,777
Q
Glom1
Glomerulus QTL 1
IDA
RGD
PMID:12397040
RGD:634618
NCBI chr X:75,294,106...120,294,106
Q
Glom15
Glomerulus QTL 15
IDA
RGD
PMID:16482158
RGD:2293335
NCBI chr13:74,862,117...101,339,893
Q
Glom16
Glomerulus QTL 16
IDA
RGD
PMID:16482158
RGD:2293335
NCBI chr16:832,236...46,053,497
Q
Glom2
Glomerulus QTL 2
IDA
RGD
PMID:12397040
RGD:634618
NCBI chr 1:222,363,780...260,522,016
Q
Glom24
Glomerulus QTL 24
IDA
RGD
PMID:16482158
RGD:2293335
NCBI chr 5:97,570,330...136,479,578
Q
Glom27
Glomerulus QTL 27
IDA
RGD
PMID:22445570
RGD:7207870
NCBI chr13:20,605,871...101,339,738
Q
Glom3
Glomerulus QTL 3
IDA
RGD
PMID:12397040
RGD:634618
Q
Glom4
Glomerulus QTL 4
IDA
RGD
PMID:14638907
RGD:730279
NCBI chr 2:20,304,672...65,304,672
Q
Glom5
Glomerulus QTL 5
IDA
RGD
PMID:14638907
RGD:730279
NCBI chr 7:96,670,164...135,012,528
Q
Glom6
Glomerulus QTL 6
IDA
RGD
PMID:14638907
RGD:730279
NCBI chr 9:64,573,531...109,573,531
Q
Glom7
Glomerulus QTL 7
IDA
RGD
PMID:14638907
RGD:730279
NCBI chr 6:71,201,409...116,201,409
Q
Glom8
Glomerulus QTL 8
IDA
RGD
PMID:14638907
RGD:730279
NCBI chr 6:86,894,788...131,894,788
Q
Iddm24
Insulin dependent diabetes mellitus QTL 24
IDA
RGD
PMID:17389329
RGD:1624306
NCBI chr 8:112,834,440...118,649,220
Q
Kiddil1
Kidney dilation QTL 1
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 6:81,132,889...104,393,926
Q
Kiddil2
Kidney dilation QTL 2
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 6:20,866,422...81,133,036
Q
Kiddil3
Kidney dilation QTL 3
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 6:81,132,889...104,393,926
Q
Kiddil4
Kidney dilation QTL 4
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 6:20,866,422...81,133,036
Q
Kiddil5
Kidney dilation QTL 5
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 2:42,804,607...157,142,209
Q
Kiddil6
Kidney dilation QTL 6
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 2:42,804,607...182,042,367
Q
Kiddil7
Kidney dilation QTL 7
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 2:219,753,301...247,136,170
Q
Kiddil8
Kidney dilation QTL 8
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 2:219,753,301...247,136,170
Q
Kiddil9
Kidney dilation QTL 9
IDA
RGD
PMID:18523158
RGD:2293631
NCBI chr 4:120,926,564...148,090,731
Q
Mcs2
Mammary carcinoma susceptibility QTL 2
IDA
RGD
PMID:9584103
RGD:61081
NCBI chr 7:19,032,807...35,526,300
Q
Mcsm1
Mammary carcinoma susceptibility modifier QTL 1
IDA
RGD
PMID:11139513
RGD:62417
NCBI chr 6:58,632,962...103,632,962
Q
Panci1
Pancreas inflammation QTL 1
IDA
RGD
PMID:11414764
RGD:619682
NCBI chr 7:116,677,189...127,103,496
Q
Pancm1
Pancreatic morphology QTL 1
IDA
RGD
PMID:9169130
RGD:61083
NCBI chr 1:181,759,564...214,537,555
Q
Plsm1
Polydactyly-luxate syndrome (PLS) morphotypes QTL 1
IDA
RGD
PMID:8997636
RGD:632346
NCBI chr 4:1...27,716,890
Q
Plsm2
Polydactyly-luxate syndrome (PLS) morphotypes QTL 2
IDA
RGD
PMID:8997636
RGD:632346
NCBI chr 4:132,422,778...177,422,778
Q
Plsm4
Polydactyly-luxate syndrome (PLS) morphotypes QTL 4
IDA
RGD
PMID:8997636
RGD:632346
NCBI chr11:54,457,534...86,241,447
Q
Prcs1
Prostate cancer susceptibility QTL 1
IDA
RGD
PMID:15805257
RGD:1358944
NCBI chr19:15,114,598...34,521,833
Q
Prcs2
Prostate cancer susceptibility QTL 2
IDA
RGD
PMID:15805257
RGD:1358944
NCBI chr20:4,606,607...17,617,956
Q
Rends1
Renal damage susceptibility QTL 1
IDA
RGD
PMID:10454439
RGD:632218
NCBI chr 1:169,537,671...214,537,671
Q
Rends2
Renal damage susceptibility QTL 2
IDA
RGD
PMID:12874092
RGD:631854
NCBI chr 1:19,333,571...56,983,283
Q
Rends3
Renal damage susceptibility QTL 3
IDA
RGD
PMID:12874092
RGD:631854
NCBI chr10:79,813,789...85,160,854
Q
Rends4
Renal damage susceptibility QTL 4
IDA
RGD
PMID:12874092
RGD:631854
NCBI chr16:1...26,727,669
Q
Rf20
Renal function QTL 20
IDA
RGD
PMID:14532335
RGD:727992
NCBI chr11:29,528,418...60,324,829
Q
Rf9
Renal function QTL 9
IDA
RGD
PMID:14532335
RGD:727992
NCBI chr 2:133,914,684...202,447,032
Q
Strs1
Sensitivity to stroke QTL 1
IDA
RGD
PMID:8696337
RGD:61093
NCBI chr 1:121,767,634...166,767,634
Q
Strs2
Sensitivity to stroke QTL 2
IDA
RGD
PMID:8696337
RGD:61093
NCBI chr 5:135,929,696...166,875,058
Q
Strs3
Sensitivity to stroke QTL 3
IDA
RGD
PMID:8696337
RGD:61093
NCBI chr 4:40,433,388...85,433,388
Q
Tescar1
Testicular tumor resistance QTL 1
IDA
RGD
PMID:15805257
RGD:1358944
NCBI chr11:1,041,931...66,113,562
Q
Toxo1
Toxoplasma gondii resistance QTL 1
IDA
RGD
PMID:16407112
RGD:1578521
NCBI chr10:52,200,030...59,378,278
Q
Vetf10
Vascular elastic tissue fragility QTL 10
IDA
RGD
PMID:17356016
RGD:8662443
NCBI chr10:6,154,182...73,453,136
Q
Vetf3
Vascular elastic tissue fragility QTL 3
IDA
RGD
PMID:17356016
RGD:8662443
NCBI chr 5:2,282,226...69,540,447
Q
Vetf4
Vascular elastic tissue fragility QTL 4
IDA
RGD
PMID:17356016
RGD:8662443
NCBI chr 3:59,242,096...157,323,038
Q
Vetf5
Vascular elastic tissue fragility QTL 5
IDA
RGD
PMID:17356016
RGD:8662443
NCBI chr 8:28,242,912...99,525,068
Q
Vetf6
Vascular elastic tissue fragility QTL 6
IDA
RGD
PMID:17356016
RGD:8662443
NCBI chr 9:36,962,359...92,058,970
Q
Wbc1
White blood cell count QTL 1
IDA
RGD
PMID:14532335
RGD:727992
NCBI chr 5:125,392,826...139,989,768
Q
Bp49
Blood pressure QTL 49
IDA
RGD
PMID:9241273
RGD:61056
NCBI chr 5:60,293,434...98,603,051
Q
Bw61
Body weight QTL61
IDA
RGD
PMID:11853145
RGD:619672
NCBI chr 1:173,108,781...218,108,781
Q
Glom10
Glomerulus QTL 10
IDA
RGD
PMID:16720678
RGD:1581737
NCBI chr11:1...35,331,169
Q
Glom11
Glomerulus QTL 11
IDA
RGD
PMID:16720678
RGD:1581737
Q
Glom12
Glomerulus QTL 12
IDA
RGD
PMID:16720678
RGD:1581737
NCBI chr 5:33,215,665...78,215,665
Q
Glom13
Glomerulus QTL 13
IDA
RGD
PMID:16720678
RGD:1581737
Q
Glom14
Glomerulus QTL 14
IDA
RGD
PMID:16720678
RGD:1581737
NCBI chr15:34,054,139...79,054,139
Q
Glom17
Glomerulus QTL 17
IDA
RGD
PMID:18682577
RGD:2312422
NCBI chr 1:166,532,971...191,278,129
Q
Glom18
Glomerulus QTL 18
IDA
RGD
PMID:18682577
RGD:2312422
NCBI chr 1:185,356,336...231,689,108
Q
Glom19
Glomerulus QTL 19
IDA
RGD
PMID:18682577
RGD:2312422
NCBI chr 4:45,456,990...146,803,430
Q
Glom20
Glomerulus QTL 20
IDA
RGD
PMID:18682577
RGD:2312422
NCBI chr11:44,285,759...82,566,702
Q
Glom21
Glomerulus QTL 21
IDA
RGD
PMID:18682577
RGD:2312422
NCBI chr18:5,185,858...40,503,530
Q
Glom9
Glomerulus QTL 9
IDA
RGD
PMID:16720678
RGD:1581737
NCBI chr 2:92,337,601...137,337,601
Q
Hcar1
Hepatocarcinoma resistance QTL 1
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr10:6,154,182...15,990,232
Q
Hcar10
Hepatocarcinoma resistance QTL 10
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 8:40,713,066...82,925,667
Q
Hcar11
Hepatocarcinoma resistance QTL 11
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 6:82,523,650...110,548,006
Q
Hcar12
Hepatocarcinoma resistance QTL 12
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 3:29,463,235...118,376,539
Q
Hcar13
Hepatocarcinoma resistance QTL 13
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr 4:1...32,584,199
Q
Hcar14
Hepatocarcinoma resistance QTL 14
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr18:51,464,733...83,218,561
Q
Hcar15
Hepatocarcinoma resistance QTL 15
IDA
RGD
PMID:15771619
RGD:1358145
NCBI chr 1:153,136,852...260,522,016
Q
Hcar2
Hepatocarcinoma resistance QTL 2
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 4:78,878,504...123,878,504
Q
Hcar3
Hepatocarcinoma resistance QTL 3
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 8:54,237,644...99,103,503
Q
Hcar4
Hepatocarcinoma resistance QTL 4
IDA
RGD
PMID:10850431
RGD:619609
NCBI chr 1:193,422,268...214,537,671
Q
Hcar5
Hepatocarcinoma resistance QTL 5
IDA
RGD
PMID:10850431
RGD:619609
NCBI chr 1:214,537,555...226,660,468
Q
Hcar6
Hepatocarcinoma resistance QTL 6
IDA
RGD
PMID:10850431
RGD:619609
Q
Hcar7
Hepatocarcinoma resistance QTL 7
IDA
RGD
PMID:10850431
RGD:619609
NCBI chr 4:70,808,386...115,808,386
Q
Hcar8
Hepatocarcinoma resistance QTL 8
IDA
RGD
PMID:10850431
RGD:619609
NCBI chr 4:123,143,783...168,143,783
Q
Hcar9
Hepatocarcinoma resistance QTL 9
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 4:109,866,907...167,139,601
Q
Hcas1
Hepatocarcinoma susceptibility QTL 1
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 7:91,412,594...129,807,172
Q
Hcas2
Hepatocarcinoma susceptibility QTL 2
IDA
RGD
PMID:10493520
RGD:619598
NCBI chr 1:5,925,874...115,540,829
Q
Hcas3
Hepatocarcinoma susceptibility QTL 3
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr 1:144,267,353...222,987,745
Q
Hcas4
Hepatocarcinoma susceptibility QTL 4
IDA
RGD
PMID:12154055
RGD:629566
NCBI chr16:4,227,609...46,975,965
Q
Hcas5
Hepatocarcinoma susceptibility QTL 5
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr 1:176,426,412...257,976,495
Q
Hcas6
Hepatocarcinoma susceptibility QTL 6
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr14:39,057,237...83,368,335
Q
Hcas7
Hepatocarcinoma susceptibility QTL 7
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr15:2,266,368...46,921,453
Q
Hcas8
Hepatocarcinoma susceptibility QTL 8
IDA
RGD
PMID:17079458
RGD:1599590
NCBI chr16:1...22,477,621
Q
Lnnr3
Liver neoplastic nodule remodeling QTL 3
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr 2:1...41,244,106
Q
Lnnr4
Liver neoplastic nodule remodeling QTL 4
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr13:1...42,356,786
Q
Lnnr5
Liver neoplastic nodule remodeling QTL 5
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr13:59,874,408...85,581,182
Q
Lnnr6
Liver neoplastic nodule remodeling QTL 6
IDA
RGD
PMID:15185337
RGD:737884
NCBI chr13:74,862,117...85,581,182
Q
Pancm2
Pancreatic morphology QTL 2
IDA
RGD
PMID:20878524
RGD:4889455
NCBI chr10:76,748,906...107,211,142
Q
Prcr1
Prostate cancer resistance QTL 1
IDA
RGD
PMID:15805257
RGD:1358944
NCBI chr 2:72,532,993...157,142,209
Q
Prcr2
Prostate cancer resistance QTL 2
IDA
RGD
PMID:15805257
RGD:1358944
NCBI chr 1:20,763,158...44,095,856
Q
Rf57
Renal function QTL 57
IDA
RGD
PMID:19584172
RGD:2316856
NCBI chr 5:59,793,528...90,450,144
Q
Rf58
Renal function QTL 58
IDA
RGD
PMID:19584172
RGD:2316856
NCBI chr 7:68,938,720...113,886,318
Q
Smcn1
Smooth muscle cell number QTL 1
IDA
RGD
PMID:15741507
RGD:1357419
NCBI chr 2:59,134,147...127,460,910
Q
Vnigr1
Vascular neointimal growth QTL 1
IDA
RGD
PMID:16434542
RGD:1578306
NCBI chr 3:149,040,888...168,026,850
Q
Vnigr2
Vascular neointimal growth QTL 2
IDA
RGD
PMID:16434542
RGD:1578306
NCBI chr 3:130,656,562...169,034,231
Q
Vnigr3
Vascular neointimal growth QTL 3
IDA
RGD
PMID:16434542
RGD:1578306
NCBI chr 3:130,656,562...169,034,231
Q
Gdil2
Gastrointestinal dilation QTL 2
IDA
RGD
PMID:25790447
RGD:10402048
NCBI chr 2:24,903,853...74,786,777
Q
Gcr3
Gastric cancer resistance QTL 3
IDA
RGD
PMID:10706129
RGD:69698
NCBI chr16:17,696,791...82,635,055
Q
Lnnr1
Liver neoplastic nodule remodeling QTL 1
IDA
RGD
PMID:12672032
RGD:629574
NCBI chr 7:34,293,282...79,293,282
Q
Lnnr2
Liver neoplastic nodule remodeling QTL 2
IDA
RGD
PMID:12672032
RGD:629574
NCBI chr 1:233,948,574...260,522,016
Q
Neuinf4
Neuroinflammation QTL 4
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 1:1...28,736,750
Q
Neuinf5
Neuroinflammation QTL 5
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 7:9,462,246...58,265,113
Q
Neuinf6
Neuroinflammation QTL 6
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr 7:1...27,829,089
Q
Neuinf7
Neuroinflammation QTL 7
IDA
RGD
PMID:19525015
RGD:2311085
NCBI chr10:72,224,939...107,211,142
Q
Neudeg1
Neurodegradation QTL 1
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 8:30,188,867...94,457,446
Q
Neudeg2
Neurodegradation QTL 2
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 5:24,838,710...44,045,280
Q
Neuinf1
Neuroinflammation QTL 1
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr 5:154,828,214...166,875,058
Q
Neuinf2
Neuroinflammation QTL 2
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr10:6,154,377...6,357,896
Q
Neuinf3
Neuroinflammation QTL 3
IDA
RGD
PMID:14586010
RGD:1358788
NCBI chr10:3,406,320...5,387,112
Q
Tspe1
Trichinella spiralis expulsion QTL 1
IDA
RGD
PMID:16465509
RGD:1578305
NCBI chr 9:61,381,434...65,691,299
Related Phenotype Data for Term "ex vivo microscopy" (MMO:0000109)
Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all